Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−5.92EUR
−216.75 MEUR
245.17 MEUR
38.99 M
About Axsome Therapeutics, Inc.
Sector
Industry
CEO
Herriott Tabuteau
Website
Headquarters
New York
Employees (FY)
545
Founded
2012
FIGI
BBG00GHB1CB1
Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview contain AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.
An aggregate view of professional's ratings.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 19X is 73.32 EUR — it has increased by 0.38% in the past 24 hours. Watch AXSOME THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange AXSOME THERAPEUTICS INC stocks are traded under the ticker 19X.
19X stock has risen by 3.62% compared to the previous week, the month change is a 6.45% rise, over the last year AXSOME THERAPEUTICS INC has showed a 9.28% decrease.
We've gathered analysts' opinions on AXSOME THERAPEUTICS INC future price: according to them, 19X price has a max estimate of 175.93 EUR and a min estimate of 89.81 EUR. Watch 19X chart and read a more detailed AXSOME THERAPEUTICS INC stock forecast: see what analysts think of AXSOME THERAPEUTICS INC and suggest that you do with its stocks.
19X stock is 1.34% volatile and has beta coefficient of 0.98. Track AXSOME THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is AXSOME THERAPEUTICS INC there?
Today AXSOME THERAPEUTICS INC has the market capitalization of 3.48 B, it has increased by 3.34% over the last week.
Yes, you can track AXSOME THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
AXSOME THERAPEUTICS INC is going to release the next earnings report on Aug 5, 2024. Keep track of upcoming events with our Earnings Calendar.
19X earnings for the last quarter are −1.33 EUR per share, whereas the estimation was −1.12 EUR resulting in a −19.55% surprise. The estimated earnings for the next quarter are −1.21 EUR per share. See more details about AXSOME THERAPEUTICS INC earnings.
AXSOME THERAPEUTICS INC revenue for the last quarter amounts to 69.51 M EUR, despite the estimated figure of 67.92 M EUR. In the next quarter, revenue is expected to reach 81.08 M EUR.
19X net income for the last quarter is −63.35 M EUR, while the quarter before that showed −89.38 M EUR of net income which accounts for 29.12% change. Track more AXSOME THERAPEUTICS INC financial stats to get the full picture.
No, 19X doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 26, 2024, the company has 545.00 employees. See our rating of the largest employees — is AXSOME THERAPEUTICS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AXSOME THERAPEUTICS INC EBITDA is −219.88 M EUR, and current EBITDA margin is −65.07%. See more stats in AXSOME THERAPEUTICS INC financial statements.
Like other stocks, 19X shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AXSOME THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AXSOME THERAPEUTICS INC technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AXSOME THERAPEUTICS INC stock shows the buy signal. See more of AXSOME THERAPEUTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.